 Marseille, France, April 28, 2021 GLOBE NEWSWIRE -- Innate Pharma SA Euronext Paris: IPH ISIN: FR0010331421; Nasdaq: IPHA Innate or the Company today announced the filing of its 2020 Universal Registration Document Document denregistrement universel for the year ending December 31, 2020 with the French market authority Autorité des Marchés Financiers AMF on April 27, 2021. It can be downloaded in French on the Companys website and on the AMFs website. 